United States Biopharmaceutical Market Report 2016

September 2016 | 120 pages | ID: U42EC99D797EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Biopharmaceutical

Revenue, means the sales value of Biopharmaceutical

This report studies sales (consumption) of Biopharmaceutical in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• A.G. Scientific, Inc. (US)
• Abbott Diagnostics (US)
• Agilent Technologies, Inc. (US)
• BD Biosciences (US)
• Beckman Coulter, Inc. (US)
• bioMerieux (France)
• Bio-Rad Laboratories, Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Gallus Immunotech, Inc. (Canada)
• GE Healthcare (UK)
• Lonza Biologics Ltd. (Switzerland)
• Merck KGaA (Germany)
• Meridian Life Science, Inc. (US)
• PerkinElmer, Inc. (US)
• Promega Corporation (US)
• Qiagen N.V. (Netherlands)
• R&D Systems (US)
• SDIX, LLC (US)
• Shimadzu Corporation (Japan)
• Takara Bio, Inc. (Japan)
• Thermo Fisher Scientific Inc. (US)
• Wako Pure Chemical Industries Ltd. (Japan)
• Waters Corp. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Biopharmaceutical in each application, can be divided into

• Medical care
• Experiment
• Application 3

Contents

United States Biopharmaceutical Market Report 2016

1 BIOPHARMACEUTICAL OVERVIEW

1.1 Product Overview and Scope of Biopharmaceutical
1.2 Classification of Biopharmaceutical
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Biopharmaceutical
  1.3.1 Medical care
  1.3.2 Experiment
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Biopharmaceutical (2011-2021)
  1.4.1 USA Biopharmaceutical Sales and Growth Rate (2011-2021)
  1.4.2 USA Biopharmaceutical Revenue and Growth Rate (2011-2021)

2 USA BIOPHARMACEUTICAL COMPETITION BY MANUFACTURERS

2.1 USA Biopharmaceutical Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Biopharmaceutical Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Biopharmaceutical Average Price by Manufactures (2015 and 2016)
2.4 Biopharmaceutical Market Competitive Situation and Trends
  2.4.1 Biopharmaceutical Market Concentration Rate
  2.4.2 Biopharmaceutical Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA BIOPHARMACEUTICAL SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Biopharmaceutical Sales and Market Share by Type (2011-2016)
3.2 USA Biopharmaceutical Revenue and Market Share by Type (2011-2016)
3.3 USA Biopharmaceutical Price by Type (2011-2016)
3.4 USA Biopharmaceutical Sales Growth Rate by Type (2011-2016)

4 USA BIOPHARMACEUTICAL SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Biopharmaceutical Sales and Market Share by Application (2011-2016)
4.2 USA Biopharmaceutical Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA BIOPHARMACEUTICAL MANUFACTURERS PROFILES/ANALYSIS

5.1 A.G. Scientific, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Biopharmaceutical Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 A.G. Scientific, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Abbott Diagnostics (US)
  5.2.2 Biopharmaceutical Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Abbott Diagnostics (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Agilent Technologies, Inc. (US)
  5.3.2 Biopharmaceutical Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Agilent Technologies, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 BD Biosciences (US)
  5.4.2 Biopharmaceutical Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 BD Biosciences (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Beckman Coulter, Inc. (US)
  5.5.2 Biopharmaceutical Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Beckman Coulter, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 bioMerieux (France)
  5.6.2 Biopharmaceutical Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 bioMerieux (France) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Bio-Rad Laboratories, Inc. (US)
  5.7.2 Biopharmaceutical Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Bio-Rad Laboratories, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 F. Hoffmann-La Roche Ltd. (Switzerland)
  5.8.2 Biopharmaceutical Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 F. Hoffmann-La Roche Ltd. (Switzerland) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Gallus Immunotech, Inc. (Canada)
  5.9.2 Biopharmaceutical Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Gallus Immunotech, Inc. (Canada) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 GE Healthcare (UK)
  5.10.2 Biopharmaceutical Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 GE Healthcare (UK) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Lonza Biologics Ltd. (Switzerland)
5.12 Merck KGaA (Germany)
5.13 Meridian Life Science, Inc. (US)
5.14 PerkinElmer, Inc. (US)
5.15 Promega Corporation (US)
5.16 Qiagen N.V. (Netherlands)
5.17 R&D Systems (US)
5.18 SDIX, LLC (US)
5.19 Shimadzu Corporation (Japan)
5.20 Takara Bio, Inc. (Japan)
5.21 Thermo Fisher Scientific Inc. (US)
5.22 Wako Pure Chemical Industries Ltd. (Japan)
5.23 Waters Corp. (US)

6 BIOPHARMACEUTICAL MANUFACTURING COST ANALYSIS

6.1 Biopharmaceutical Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biopharmaceutical

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Biopharmaceutical Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biopharmaceutical Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA BIOPHARMACEUTICAL MARKET FORECAST (2016-2021)

10.1 USA Biopharmaceutical Sales, Revenue Forecast (2016-2021)
10.2 USA Biopharmaceutical Sales Forecast by Type (2016-2021)
10.3 USA Biopharmaceutical Sales Forecast by Application (2016-2021)
10.4 Biopharmaceutical Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biopharmaceutical
Table Classification of Biopharmaceutical
Figure USA Sales Market Share of Biopharmaceutical by Type in 2015
Table Application of Biopharmaceutical
Figure USA Sales Market Share of Biopharmaceutical by Application in 2015
Figure Medical care Examples
Figure Experiment Examples
Figure USA Biopharmaceutical Sales and Growth Rate (2011-2021)
Figure USA Biopharmaceutical Revenue and Growth Rate (2011-2021)
Table USA Biopharmaceutical Sales of Key Manufacturers (2015 and 2016)
Table USA Biopharmaceutical Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biopharmaceutical Sales Share by Manufacturers
Figure 2016 Biopharmaceutical Sales Share by Manufacturers
Table USA Biopharmaceutical Revenue by Manufacturers (2015 and 2016)
Table USA Biopharmaceutical Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Biopharmaceutical Revenue Share by Manufacturers
Table 2016 USA Biopharmaceutical Revenue Share by Manufacturers
Table USA Market Biopharmaceutical Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Biopharmaceutical Average Price of Key Manufacturers in 2015
Figure Biopharmaceutical Market Share of Top 3 Manufacturers
Figure Biopharmaceutical Market Share of Top 5 Manufacturers
Table USA Biopharmaceutical Sales by Type (2011-2016)
Table USA Biopharmaceutical Sales Share by Type (2011-2016)
Figure USA Biopharmaceutical Sales Market Share by Type in 2015
Table USA Biopharmaceutical Revenue and Market Share by Type (2011-2016)
Table USA Biopharmaceutical Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biopharmaceutical by Type (2011-2016)
Table USA Biopharmaceutical Price by Type (2011-2016)
Figure USA Biopharmaceutical Sales Growth Rate by Type (2011-2016)
Table USA Biopharmaceutical Sales by Application (2011-2016)
Table USA Biopharmaceutical Sales Market Share by Application (2011-2016)
Figure USA Biopharmaceutical Sales Market Share by Application in 2015
Table USA Biopharmaceutical Sales Growth Rate by Application (2011-2016)
Figure USA Biopharmaceutical Sales Growth Rate by Application (2011-2016)
Table A.G. Scientific, Inc. (US) Basic Information List
Table A.G. Scientific, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Figure A.G. Scientific, Inc. (US) Biopharmaceutical Sales Market Share (2011-2016)
Table Abbott Diagnostics (US) Basic Information List
Table Abbott Diagnostics (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Diagnostics (US) Biopharmaceutical Sales Market Share (2011-2016)
Table Agilent Technologies, Inc. (US) Basic Information List
Table Agilent Technologies, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies, Inc. (US) Biopharmaceutical Sales Market Share (2011-2016)
Table BD Biosciences (US) Basic Information List
Table BD Biosciences (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table BD Biosciences (US) Biopharmaceutical Sales Market Share (2011-2016)
Table Beckman Coulter, Inc. (US) Basic Information List
Table Beckman Coulter, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beckman Coulter, Inc. (US) Biopharmaceutical Sales Market Share (2011-2016)
Table bioMerieux (France) Basic Information List
Table bioMerieux (France) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table bioMerieux (France) Biopharmaceutical Sales Market Share (2011-2016)
Table Bio-Rad Laboratories, Inc. (US) Basic Information List
Table Bio-Rad Laboratories, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio-Rad Laboratories, Inc. (US) Biopharmaceutical Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Biopharmaceutical Sales Market Share (2011-2016)
Table Gallus Immunotech, Inc. (Canada) Basic Information List
Table Gallus Immunotech, Inc. (Canada) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gallus Immunotech, Inc. (Canada) Biopharmaceutical Sales Market Share (2011-2016)
Table GE Healthcare (UK) Basic Information List
Table GE Healthcare (UK) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare (UK) Biopharmaceutical Sales Market Share (2011-2016)
Table Lonza Biologics Ltd. (Switzerland) Basic Information List
Table Lonza Biologics Ltd. (Switzerland) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Biologics Ltd. (Switzerland) Biopharmaceutical Sales Market Share (2011-2016)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA (Germany) Biopharmaceutical Sales Market Share (2011-2016)
Table Meridian Life Science, Inc. (US) Basic Information List
Table Meridian Life Science, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Meridian Life Science, Inc. (US) Biopharmaceutical Sales Market Share (2011-2016)
Table PerkinElmer, Inc. (US) Basic Information List
Table PerkinElmer, Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table PerkinElmer, Inc. (US) Biopharmaceutical Sales Market Share (2011-2016)
Table Promega Corporation (US) Basic Information List
Table Promega Corporation (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Promega Corporation (US) Biopharmaceutical Sales Market Share (2011-2016)
Table Qiagen N.V. (Netherlands) Basic Information List
Table Qiagen N.V. (Netherlands) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qiagen N.V. (Netherlands) Biopharmaceutical Sales Market Share (2011-2016)
Table R&D Systems (US) Basic Information List
Table R&D Systems (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table R&D Systems (US) Biopharmaceutical Sales Market Share (2011-2016)
Table SDIX, LLC (US) Basic Information List
Table SDIX, LLC (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table SDIX, LLC (US) Biopharmaceutical Sales Market Share (2011-2016)
Table Shimadzu Corporation (Japan) Basic Information List
Table Shimadzu Corporation (Japan) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shimadzu Corporation (Japan) Biopharmaceutical Sales Market Share (2011-2016)
Table Takara Bio, Inc. (Japan) Basic Information List
Table Takara Bio, Inc. (Japan) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takara Bio, Inc. (Japan) Biopharmaceutical Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (US) Basic Information List
Table Thermo Fisher Scientific Inc. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Inc. (US) Biopharmaceutical Sales Market Share (2011-2016)
Table Wako Pure Chemical Industries Ltd. (Japan) Basic Information List
Table Wako Pure Chemical Industries Ltd. (Japan) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wako Pure Chemical Industries Ltd. (Japan) Biopharmaceutical Sales Market Share (2011-2016)
Table Waters Corp. (US) Basic Information List
Table Waters Corp. (US) Biopharmaceutical Sales, Revenue, Price and Gross Margin (2011-2016)
Table Waters Corp. (US) Biopharmaceutical Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biopharmaceutical
Figure Manufacturing Process Analysis of Biopharmaceutical
Figure Biopharmaceutical Industrial Chain Analysis
Table Raw Materials Sources of Biopharmaceutical Major Manufacturers in 2015
Table Major Buyers of Biopharmaceutical
Table Distributors/Traders List
Figure USA Biopharmaceutical Production and Growth Rate Forecast (2016-2021)
Figure USA Biopharmaceutical Revenue and Growth Rate Forecast (2016-2021)
Table USA Biopharmaceutical Production Forecast by Type (2016-2021)
Table USA Biopharmaceutical Consumption Forecast by Application (2016-2021)